$36.330
-0.069 (-0.19%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PCRX Prediction & Forecast by Similar Chart Analysis
Alphio's PCRX stock price prediction model matches the current Pacira Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.18 (-3.35%). The 1-week path is $30.11 (-17.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Pacira Biosciences Inc Stock?
Pacira Biosciences Inc is currently a hold. The stock price is at $36.31, just below the acquisition price of $36.50, which limits upside potential. The RSI is at 93.272, indicating the stock is overbought, suggesting caution. While the acquisition by Viatris represents a 45% premium over the previous closing price, the significant insider selling (636.27% increase) raises concerns about future performance post-acquisition. The main risk is the stock's current valuation with a P/E ratio of 99.1, which is quite high, indicating potential overvaluation.
PCRX stock price ended at $36.33 on Thursday, after losing -0.19%
Pacira Biosciences Inc (PCRX) last closed at $36.4, gaining +0.25%. These facts feed the 1-day and 1-week PCRX price prediction above.
Analyst Consensus
Pacira Biosciences Inc (PCRX): 10 buy, 5 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Pacira Biosciences Inc (PCRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches PCRX, ranked by similarity.
Seasonality analysis for PCRX
Historically the probability of a positive October return for PCRX is 59.65%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PCRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $26.30 | $28.76 | $30.14 | -21.00% |
| Nov 2026 | $18.11 | $23.10 | $25.77 | -36.54% |
| Dec 2026 | $21.55 | $25.71 | $25.82 | -29.37% |
In 2026, Pacira Biosciences Inc (PCRX) is projected to range from $18.11 to $30.14.
Pacira Biosciences Inc 2026 monthly forecast
In Oct 2026, Pacira Biosciences Inc is projected to average $28.76, with a low of $26.30 and high of $30.14.
In Nov 2026, Pacira Biosciences Inc is projected to average $23.10, with a low of $18.11 and high of $25.77.
In Dec 2026, Pacira Biosciences Inc is projected to average $25.71, with a low of $21.55 and high of $25.82.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.